Developments AUM Biosciences going public through merger with Mountain Crest Acquisition Closely-held AUM Biosciences, which is advancing a broad portfolio of precision oncology therapeutics, entered into a definitive business combination agreement with Mountain Crest Acquisition Corp. V (NASDAQ:MCAG). The... October 21, 2022